|
시장보고서
상품코드
1668344
카테터 시장 - 산업규모, 점유율, 동향, 기회, 예측, 제품 유형별, 최종 용도별, 지역별, 경쟁별(2020-2030년)Catheter Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product Type, By End Use, By Region and Competition, 2020-2030F |
||||||
카테터 세계 시장 규모는 2024년에 584억 5,000만 달러로 평가되었고, 2030년에는 802억 7,000만 달러에 이르고, 예측 기간 중 CAGR은 5.39%를 나타낼 것으로 전망됩니다.
이 시장은 만성 질환 증가, 세계 인구의 고령화, 의료 기술의 진보 등을 배경으로 최근 몇 년간 큰 성장을 이루고 있습니다. 카테터는 심장혈관, 비뇨기, 신경혈관, 정맥 내 치료 등 다양한 용도에 사용되는 중요한 의료기기입니다. 병원, 외래수술센터(ASC), 재택 헬스케어 등에서 널리 사용되고 있는 것이 이 확대에 기여하고 있습니다. 게다가, 침습을 낮추는 것에 대한 의식이 높아지면 혁신적인 카테터 기술에 대한 수요가 가속화되고 있습니다.
| 시장 개요 | |
|---|---|
| 예측 기간 | 2026-2030년 |
| 시장 규모 : 2024년 | 584억 5,000만 달러 |
| 시장 규모 : 2030년 | 802억 7,000만 달러 |
| CAGR : 2025-2030년 | 5.39% |
| 급성장 부문 | 심혈관 카테터 |
| 최대 시장 | 북미 |
카테터 시장의 성장을 견인하는 주요 요인은 심혈관 질환(CVD)과 비뇨기 질환의 이환율이 증가하는 것입니다. 혈관 조영 카테터 및 전기 생리 카테터와 같은 심혈관 카테터는 심장 질환의 진단과 치료에 널리 사용됩니다. 마찬가지로 요도 카테터는 요실금 및 기타 방광 관련 문제가있는 환자, 특히 노인에게 필수적입니다. 만성 질환의 유병률 증가와 수술 수 증가는 카테터 수요를 유지할 것으로 예상됩니다.
카테터 설계와 재료의 기술적 진보가 시장 확대의 열쇠를 잡고 있습니다. 항균제 코팅 카테터 및 약물 용출 카테터의 개발로 카테터 치료와 관련된 감염 위험이 크게 감소했습니다. 또한 실시간 모니터링용 센서가 장착된 스마트 카테터의 출현으로 환자의 안전성과 치료 성적이 향상되었습니다. 제조업체 각 회사는 또한 카테터의 내구성과 성능을 향상시키고 환자 친화적인 카테터를 실현하기 위해 생체 적합성 재료에 주력하고 있습니다.
만성 질환의 유병률 상승
입원과 외과 수술 증가
가격압력과 상환문제
공급망 혼란과 재료 부족
기술 진보
The global catheter market was valued at USD 58.45 billion in 2024 and is projected to reach USD 80.27 billion by 2030, growing at a compound annual growth rate (CAGR) of 5.39% during the forecast period. The market has experienced significant growth in recent years, driven by the increasing prevalence of chronic diseases, an aging global population, and advancements in medical technology. Catheters are vital medical devices used in a variety of applications, including cardiovascular, urology, neurovascular, and intravenous procedures. Their widespread use across hospitals, ambulatory surgical centers, and home healthcare settings has contributed to this expansion. Furthermore, rising awareness of minimally invasive procedures has accelerated demand for innovative catheter technologies.
| Market Overview | |
|---|---|
| Forecast Period | 2026-2030 |
| Market Size 2024 | USD 58.45 Billion |
| Market Size 2030 | USD 80.27 Billion |
| CAGR 2025-2030 | 5.39% |
| Fastest Growing Segment | Cardiovascular Catheter |
| Largest Market | North America |
A major factor driving growth in the catheter market is the rising incidence of cardiovascular diseases (CVDs) and urinary disorders. Cardiovascular catheters, such as angiography and electrophysiology catheters, are widely used in the diagnosis and treatment of heart conditions. Similarly, urinary catheters are essential for patients with urinary incontinence and other bladder-related issues, particularly in the elderly. The increasing prevalence of chronic diseases, coupled with the rising number of surgical procedures, is expected to sustain the demand for catheters.
Technological advancements in catheter design and materials have been key in expanding the market. The development of antimicrobial-coated and drug-eluting catheters has significantly reduced infection risks associated with catheterization. Additionally, the emergence of smart catheters, equipped with sensors for real-time monitoring, has improved patient safety and treatment outcomes. Manufacturers are also focusing on biocompatible materials to enhance the durability and performance of catheters, making them more patient-friendly.
Key Market Drivers
Rising Prevalence of Chronic Diseases
The global catheter market is experiencing strong growth, largely driven by the increasing prevalence of chronic diseases, such as cardiovascular disorders, diabetes, urinary incontinence, and neurological conditions. These diseases often require continuous treatment, surgical procedures, and hospital care, with catheters playing a crucial role in patient management. Additionally, the growing geriatric population, technological advancements in catheter design, and the expansion of healthcare infrastructure worldwide have further increased demand for these devices.
Cardiovascular diseases (CVDs) are a leading cause of death globally, with conditions such as coronary artery disease, heart failure, and arrhythmias requiring catheter-based interventions. According to the World Health Organization (WHO), CVDs cause approximately 17.9 million deaths annually, underscoring the need for advanced cardiac treatments. Catheters are crucial in procedures such as angioplasty, electrophysiology studies, and cardiac catheterization. As minimally invasive techniques gain popularity, the demand for advanced cardiovascular catheters, including balloon catheters, electrophysiology catheters, and guiding catheters, has increased. The growing number of catheter-based cardiac ablation procedures to treat atrial fibrillation further boosts market demand. Moreover, innovations like steerable catheters and bioresorbable stents have enhanced the efficacy of catheter-based cardiac interventions.
Diabetes is another significant driver of catheter demand, as the condition is associated with various complications, such as kidney disease, neuropathy, and urinary retention, which often require catheter interventions. The International Diabetes Federation (IDF) estimates that over 537 million adults were living with diabetes in 2021, with the number expected to reach 783 million by 2045. For diabetic patients with end-stage renal disease (ESRD), hemodialysis is a critical treatment, requiring the use of tunneled and non-tunneled dialysis catheters. Furthermore, insulin pump therapy, which uses catheter-based infusion sets, is becoming more popular for better glycemic control, contributing to market growth.
Urinary incontinence and other bladder disorders are increasingly common, particularly among the aging population. Conditions such as benign prostatic hyperplasia (BPH), neurogenic bladder, and spinal cord injuries often necessitate catheterization for urine drainage. Foley catheters, intermittent catheters, and external catheters are commonly used for managing urinary retention and incontinence. The aging population is a major factor driving the growing demand for urinary catheters. According to the United Nations, the number of individuals aged 65 and older is expected to double by 2050, reaching 1.5 billion. As age-related urological disorders become more prevalent, the need for long-term catheter use in home healthcare settings is increasing. Additionally, the rising acceptance of self-catheterization for greater patient independence is accelerating market growth.
Increasing Hospitalizations and Surgical Procedures
The global catheter market is also expanding due to the rising number of hospitalizations and surgical procedures. Catheters are essential medical devices used in numerous diagnostic and therapeutic applications, making them indispensable in modern healthcare. The growing prevalence of chronic diseases, combined with advancements in medical technology, has significantly increased catheter demand. As healthcare providers aim to improve patient outcomes and minimize complications, the catheter market is set for continued growth.
The World Health Organization (WHO) reports that millions of people undergo surgical procedures annually, with surgery contributing to approximately 13% of global disability-adjusted life years (DALYs). An important driver of market growth is the increasing number of surgical interventions across various medical specialties. CVDs, a leading cause of global mortality, often require frequent catheter-based medical interventions. Procedures such as angioplasty, stent placement, and electrophysiology studies rely heavily on the use of cardiovascular catheters. The increasing incidence of heart diseases, driven by factors like aging populations, sedentary lifestyles, and poor dietary habits, has led to a higher number of cardiac surgeries and catheter-based treatments.
Key Market Challenges
Pricing Pressure and Reimbursement Issues
The catheter market is highly competitive, resulting in significant pricing pressures among manufacturers. Healthcare providers and governments, especially in cost-sensitive regions, are demanding lower prices for medical devices, which erodes profit margins for companies. Furthermore, reimbursement policies vary across countries, impacting the affordability of catheters for patients. In some regions, limited insurance coverage or restrictive reimbursement policies may reduce accessibility to advanced catheter technologies, hindering market growth.
Supply Chain Disruptions and Material Shortages
The global supply chain for medical devices, including catheters, has been significantly disrupted by geopolitical tensions, trade restrictions, and logistical bottlenecks. The COVID-19 pandemic exposed vulnerabilities in supply chains, leading to shortages of essential raw materials such as silicone, latex, and polyurethane, which are critical in catheter manufacturing. These disruptions have resulted in increased production costs and delays in product availability, affecting both manufacturers and healthcare providers.
Key Market Trends
Technological Advancements
The catheter market is experiencing substantial growth driven by rapid technological innovations. Advances in catheter materials, design, and functionality are enhancing patient comfort, reducing infection risks, and improving overall procedural efficiency. Key innovations include the development of antimicrobial coatings, hydrophilic surface modifications, and the use of biocompatible materials like silicone and polyurethane, which have improved flexibility, durability, and compatibility with the human body. These advancements make catheters more effective and patient-friendly, further driving market expansion.
Report Scope
This report provides a detailed analysis of the global catheter market, segmented into the following categories: